ionis-ttr rx
Nucleic acidexperimental
Clinical trial activity
2 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
2
Phase 3
2
Phase 4
0
Earliest trial started Dec 1, 2012 (NCT01737398)
Timeline
2010s
- Jan 1, 2012
Earliest Phase 3 Sponsor(trial)
Indications
Mechanism of action
- TransthyretinAGONIST
TTR agonist
Chemistry & pharmacology
- Multi-specific
- No
Oral
No
Parenteral
No
Topical
No
Also known as
- ionis-ttr rx
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT02175004 | Phase 3 | Jun 1, 2014 | GlaxoSmithKline, Ionis Pharmaceuticals, Inc. |
| NCT01737398 | Phase 3 | Dec 1, 2012 | GlaxoSmithKline, Ionis Pharmaceuticals, Inc. |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| GlaxoSmithKline | For profit | 2 | 0 | 1 | 2012 |
| Ionis Pharmaceuticals, Inc. | For profit | 2 | 2 | 1 | 2012 |
2 organizations
Page 1 / 1